Cambridge Investment Research Advisors’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $754K | Sell |
10,272
-1,733
| -14% | -$127K | ﹤0.01% | 2175 |
|
|
2025
Q1 | $1.37M | Sell |
12,005
-7,761
| -39% | -$886K | ﹤0.01% | 1620 |
|
|
2024
Q4 | $996K | Sell |
19,766
-7,089
| -26% | -$357K | ﹤0.01% | 1878 |
|
|
2024
Q3 | $1.24M | Sell |
26,855
-259,395
| -91% | -$12M | ﹤0.01% | 1705 |
|
|
2024
Q2 | $9.3M | Sell |
286,250
-38,021
| -12% | -$1.24M | 0.03% | 497 |
|
|
2024
Q1 | $8.17M | Buy |
324,271
+313,543
| +2,923% | +$7.9M | 0.03% | 531 |
|
|
2023
Q4 | $348K | Sell |
10,728
-162,724
| -94% | -$5.28M | ﹤0.01% | 2485 |
|
|
2023
Q3 | $4.73M | Buy |
+173,452
| New | +$4.73M | 0.02% | 680 |
|
|
2023
Q2 | – | Sell |
-366,220
| Closed | -$7.93M | – | 3193 |
|
|
2023
Q1 | $7.93M | Buy |
+366,220
| New | +$7.93M | 0.04% | 440 |
|